SEHK:2142Biotechs
A Look at HBM Holdings (SEHK:2142) Valuation Following AI-Focused Partnership With Evinova China
HBM Holdings (SEHK:2142) has announced a strategic partnership with Evinova China to leverage artificial intelligence and digital technologies in biologics research and development. This move is expected to add momentum to its innovation pipeline and market positioning.
See our latest analysis for HBM Holdings.
HBM Holdings’ latest surge, up 4% in a single day and 11.6% over the last week, follows the announcement of its AI-driven partnership with Evinova China. This signals that investors...